Interpharm Holdings - 52 Year Dividend History | IPAH

Historical dividend payout and yield for Interpharm Holdings (IPAH) since 1972. The current TTM dividend payout for Interpharm Holdings (IPAH) as of October 29, 2024 is $0.00. The current dividend yield for Interpharm Holdings as of October 29, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Interpharm Holdings, Inc., through its wholly owned subsidiary, Interpharm, Inc., is engaged in the business of developing, manufacturing and marketing generic prescription strength and over-the-counter pharmaceuticals. The Company sells its products under its own label to the major retailers, wholesalers, managed care organizations and national distributors, and under private label to wholesalers, distributors, repackagers and other manufacturers. The Company manufactured and marketed 36 generic pharmaceutical products, which represent various oral dosage strengths for 11 products and different dosage strengths for 25 of these products.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $17.665B 6.46
Dr Reddy's Laboratories (RDY) India $11.637B 22.20
BridgeBio Pharma (BBIO) United States $6.915B 0.00
Bausch Health Cos (BHC) Canada $2.036B 1.47
Supernus Pharmaceuticals (SUPN) United States $1.813B 16.92
Amphastar Pharmaceuticals (AMPH) United States $1.164B 7.04
Taysha Gene Therapies (TSHA) United States $0.373B 0.00
Personalis (PSNL) United States $0.336B 0.00
Assembly Biosciences (ASMB) United States $0.088B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00